142 related articles for article (PubMed ID: 33438471)
21. Dangerous Duplicity: The Dual Functions of Casein Kinase 1 in Parasite Biology and Host Subversion.
Rachidi N; Knippschild U; Späth GF
Front Cell Infect Microbiol; 2021; 11():655700. PubMed ID: 33869086
[TBL] [Abstract][Full Text] [Related]
22. Functional analysis of the rodent CK1tau mutation in the circadian clock of a marine unicellular alga.
van Ooijen G; Martin SF; Barrios-Llerena ME; Hindle M; Le Bihan T; O'Neill JS; Millar AJ
BMC Cell Biol; 2013 Oct; 14():46. PubMed ID: 24127907
[TBL] [Abstract][Full Text] [Related]
23. Discovery of N6-phenyl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamine derivatives as novel CK1 inhibitors using common-feature pharmacophore model based virtual screening and hit-to-lead optimization.
Yang LL; Li GB; Yan HX; Sun QZ; Ma S; Ji P; Wang ZR; Feng S; Zou J; Yang SY
Eur J Med Chem; 2012 Oct; 56():30-8. PubMed ID: 22944772
[TBL] [Abstract][Full Text] [Related]
24. Assessing the Inhibitory Potential of Kinase Inhibitors In Vitro: Major Pitfalls and Suggestions for Improving Comparability of Data Using CK1 Inhibitors as an Example.
Roth A; Gihring A; Göser F; Peifer C; Knippschild U; Bischof J
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443486
[TBL] [Abstract][Full Text] [Related]
25. Discovery of Inhibitor of Wnt Production 2 (IWP-2) and Related Compounds As Selective ATP-Competitive Inhibitors of Casein Kinase 1 (CK1) δ/ε.
García-Reyes B; Witt L; Jansen B; Karasu E; Gehring T; Leban J; Henne-Bruns D; Pichlo C; Brunstein E; Baumann U; Wesseler F; Rathmer B; Schade D; Peifer C; Knippschild U
J Med Chem; 2018 May; 61(9):4087-4102. PubMed ID: 29630366
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of gamma-secretase by the CK1 inhibitor IC261 does not depend on CK1delta.
Höttecke N; Liebeck M; Baumann K; Schubenel R; Winkler E; Steiner H; Schmidt B
Bioorg Med Chem Lett; 2010 May; 20(9):2958-63. PubMed ID: 20350806
[TBL] [Abstract][Full Text] [Related]
27. Gene expression levels of Casein kinase 1 (CK1) isoforms are correlated to adiponectin levels in adipose tissue of morbid obese patients and site-specific phosphorylation mediated by CK1 influences multimerization of adiponectin.
Xu P; Fischer-Posovszky P; Bischof J; Radermacher P; Wabitsch M; Henne-Bruns D; Wolf AM; Hillenbrand A; Knippschild U
Mol Cell Endocrinol; 2015 May; 406():87-101. PubMed ID: 25724478
[TBL] [Abstract][Full Text] [Related]
28. Protein kinases CK1 and CK2 as new targets for neurodegenerative diseases.
Perez DI; Gil C; Martinez A
Med Res Rev; 2011 Nov; 31(6):924-54. PubMed ID: 20577972
[TBL] [Abstract][Full Text] [Related]
29. CK1 delta inhibition: an emerging strategy to combat neurodegenerative diseases.
Varano F; Catarzi D; Calenda S; Vigiani E; Colotta V
Future Med Chem; 2022 Aug; 14(15):1111-1113. PubMed ID: 35801420
[No Abstract] [Full Text] [Related]
30. Potent, non-covalent reversible BTK inhibitors with 8-amino-imidazo[1,5-a]pyrazine core featuring 3-position bicyclic ring substitutes.
Liu J; Guiadeen D; Krikorian A; Gao X; Wang J; Babu Boga S; Alhassan AB; Yu W; Selyutin O; Yu Y; Anand R; Xu J; Kelly J; Duffy JL; Liu S; Yang C; Wu H; Cai J; Bennett C; Maloney KM; Tyagarajan S; Gao YD; Fischmann TO; Presland J; Mansueto M; Xu Z; Leccese E; Zhang-Hoover J; Knemeyer I; Garlisi CG; Stivers P; Brandish PE; Hicks A; Kim R; Kozlowski JA
Bioorg Med Chem Lett; 2020 Sep; 30(17):127390. PubMed ID: 32738973
[TBL] [Abstract][Full Text] [Related]
31. The identification of novel p38α isoform selective kinase inhibitors having an unprecedented p38α binding mode.
Wrobleski ST; Lin S; Dhar TG; Dyckman AJ; Li T; Pitt S; Zhang R; Fan Y; Doweyko AM; Tokarski JS; Kish KF; Kiefer SE; Sack JS; Newitt JA; Witmer MR; McKinnon M; Barrish JC; Dodd JH; Schieven GL; Leftheris K
Bioorg Med Chem Lett; 2013 Jul; 23(14):4120-6. PubMed ID: 23746475
[TBL] [Abstract][Full Text] [Related]
32. Dysbindin structural homologue CK1BP is an isoform-selective binding partner of human casein kinase-1.
Yin H; Laguna KA; Li G; Kuret J
Biochemistry; 2006 Apr; 45(16):5297-308. PubMed ID: 16618118
[TBL] [Abstract][Full Text] [Related]
33. Dynamic conformational ensembles regulate casein kinase-1 isoforms: Insights from molecular dynamics and molecular docking studies.
Singh SP; Gupta DK
Comput Biol Chem; 2016 Apr; 61():39-46. PubMed ID: 26788877
[TBL] [Abstract][Full Text] [Related]
34. Cardiomyocyte differentiation of pluripotent stem cells with SB203580 analogues correlates with Wnt pathway CK1 inhibition independent of p38 MAPK signaling.
Laco F; Low JL; Seow J; Woo TL; Zhong Q; Seayad J; Liu Z; Wei H; Reuveny S; Elliott DA; Chai CL; Oh SK
J Mol Cell Cardiol; 2015 Mar; 80():56-70. PubMed ID: 25528965
[TBL] [Abstract][Full Text] [Related]
35. Casein kinase I gamma subfamily. Molecular cloning, expression, and characterization of three mammalian isoforms and complementation of defects in the Saccharomyces cerevisiae YCK genes.
Zhai L; Graves PR; Robinson LC; Italiano M; Culbertson MR; Rowles J; Cobb MH; DePaoli-Roach AA; Roach PJ
J Biol Chem; 1995 May; 270(21):12717-24. PubMed ID: 7759525
[TBL] [Abstract][Full Text] [Related]
36. A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex.
Hämmerlein A; Weiske J; Huber O
Cell Mol Life Sci; 2005 Mar; 62(5):606-18. PubMed ID: 15747065
[TBL] [Abstract][Full Text] [Related]
37. Casein kinase 1 and Wnt/β-catenin signaling.
Cruciat CM
Curr Opin Cell Biol; 2014 Dec; 31():46-55. PubMed ID: 25200911
[TBL] [Abstract][Full Text] [Related]
38. Identification and Profiling of a Selective and Brain Penetrant Radioligand for in Vivo Target Occupancy Measurement of Casein Kinase 1 (CK1) Inhibitors.
Wager TT; Galatsis P; Chandrasekaran RY; Butler TW; Li J; Zhang L; Mente S; Subramanyam C; Liu S; Doran AC; Chang C; Fisher K; Grimwood S; Hedde JR; Marconi M; Schildknegt K
ACS Chem Neurosci; 2017 Sep; 8(9):1995-2004. PubMed ID: 28609096
[TBL] [Abstract][Full Text] [Related]
39. Regulation of Alzheimer's disease amyloid-beta formation by casein kinase I.
Flajolet M; He G; Heiman M; Lin A; Nairn AC; Greengard P
Proc Natl Acad Sci U S A; 2007 Mar; 104(10):4159-64. PubMed ID: 17360493
[TBL] [Abstract][Full Text] [Related]
40. D4476, a cell-permeant inhibitor of CK1, suppresses the site-specific phosphorylation and nuclear exclusion of FOXO1a.
Rena G; Bain J; Elliott M; Cohen P
EMBO Rep; 2004 Jan; 5(1):60-5. PubMed ID: 14710188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
